Background illustration for clinical trials search

Paid Clinical Trials Des Moines

Discover 219 paid clinical trials in Des Moines, Iowa. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

for
Obesity, Overweight
Location: West Des Moines IA, Topeka KS, City of Saint Peters MO,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT06143956

Phase 2, Recruiting
Active & Responsive

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

for
Obesity, Overweight
Location: West Des Moines IA, Topeka KS, Troy MI, Sarnia,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07321886

Phase 3, Recruiting
Active & Responsive

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome
Location: West Des Moines IA, Lincoln NE, Minneapolis MN,
Sponsor: Cleerly, Inc.

Sex: All

Age: 55+

Code: NCT06112418

Recruiting
Active & Responsive

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

for
Percutaneous Coronary Intervention,
Location: West Des Moines IA, Omaha NE, Lincoln NE, Mankato MN,
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT06909565

Recruiting
Active & Responsive

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

for
Cardiovascular Disease
Location: West Des Moines IA, Lincoln NE, Rochester MN,
Sponsor: Amgen

Sex: All

Age: 50 - 70+

Code: NCT07136012

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Assessment of CCM in HF With Higher Ejection Fraction

for
Heart Failure, Heart Failure With Preserved Ejection Fraction,
Location: West Des Moines IA, Iowa City IA, Lincoln NE,
Sponsor: Impulse Dynamics

Sex: All

Age: 18+

Code: NCT05064709

Recruiting
Active & Responsive

Encore PFO Closure Device - The PerFOrm Trial

for
Patent Foramen Ovale, Cryptogenic Stroke
Location: West Des Moines IA, Omaha NE, Kansas City KS,
Sponsor: Encore Medical Inc.

Sex: All

Age: 18 - 60

Code: NCT05537753

Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

for
Crohn's Disease
Location: Clive IA, Liberty MO, Rochester MN, Kansas City KS,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 16 - 70+

Code: NCT06430801

Phase 3, Recruiting
Active & Responsive

Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation

for
Paroxysmal Atrial Fibrillation (PAF),
Location: West Des Moines IA, Jonesboro AR, Columbus OH, Tyler TX,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT07575269

Recruiting
Active & Responsive

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

for
COPD
Location: West Des Moines IA, Minneapolis MN, Chicago IL,
Sponsor: Temple University

Sex: All

Age: 30+

Code: NCT05204888

Recruiting
Active & Responsive

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

for
Macular Degeneration, Age-Related Macular Degeneration,
Location: West Des Moines IA, Lenexa KS, Edina MN, Joliet IL,
Sponsor: EyeBiotech Ltd.

Sex: All

Age: 50+

Code: NCT07496567

Phase 2, Phase 3, Recruiting
Active & Responsive

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Ames IA, Marshalltown IA, Fort Dodge IA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06589804

Phase 3, Recruiting
Active & Responsive

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

for
Atherosclerotic Cardiovascular Disease, Overweight, Obesity
Location: Ames IA, Omaha NE, Papillion NE, Davenport IA,
Sponsor: Amgen

Sex: All

Age: 45 - 70+

Code: NCT07037433

Phase 3, Recruiting

Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital

for
COPD
Location: Des Moines IA, Birmingham AL, Philadelphia PA,
Sponsor: Fisher and Paykel Healthcare

Sex: All

Age: 22+

Code: NCT07222410

Recruiting

Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease

for
Arterial Disease of Legs, Below-the-knee Obstruction,
Location: Des Moines IA, Davenport IA, Cincinnati OH, Plano TX,
Sponsor: Concept Medical Inc.

Sex: All

Age: 21+

Code: NCT06182397

Recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Des Moines IA, Iowa City IA, Omaha NE, Rochester MN,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT06401330

Phase 3, Recruiting

Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study

for
Malignant Digestive System Neoplasm,
Location: Des Moines IA, Cedar Rapids IA, Liberty MO,
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 18+

Code: NCT07215624

Recruiting

Quality of End-of-Life Care for Children With Cancer

for
Childhood Hematopoietic and Lymphatic System Neoplasm,
Location: Des Moines IA, Kansas City MO, Green Bay WI,
Sponsor: Children's Oncology Group

Sex: All

Age: 18+

Code: NCT07412002

Recruiting

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for
Rhabdomyosarcoma
Location: Des Moines IA, Omaha NE, Kansas City MO, Madison WI,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT07466316

Phase 3, Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: Des Moines IA, Iowa City IA, Omaha NE, Rochester MN,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase 3, Recruiting